Skip to main content
. Author manuscript; available in PMC: 2016 Jan 3.
Published in final edited form as: Am J Surg Pathol. 2015 Jan;39(1):25–34. doi: 10.1097/PAS.0000000000000343

Table 1. Biomarkers for the detection of hepatocellular differentiation.

Target Sensitivity Other tumors commonly positive Poorly differentiated HCCs
AFP2,10 Oncofetal protein 30-50% Germ cell tumors Typically negative
Hep Par 15,6 Carbamoyl phosphatase synthetase (urea cycle) >90%, staining may be patchy Lung, colon, esophageal, and gastric carcinoma <50%
CD10 and polyclonal CEA2,8 Canalicular staining –cross reactivity to biliary glycoprotein 60-90% Diffuse cytoplasmic staining often seen in adenocarcinomas 25%
Glypican 38 Oncofetal antigen 63-80% Non seminomatous germ cells tumors, squamous cell carcinoma lung, liposarcoma, Melanoma 57-83%
Arginase-115,23 Enzyme involved in the hydrolysis of arginine to ornithine and urea 96% Rare 86
ISH Albumin12,13,14 Major protein in serum >95% None >95%